- Home
- ECF vs ALEC Comparison
ECF vs ALEC Comparison
Compare ECF & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECF
- ALEC
- Stock Information
- Founded
- ECF 1986
- ALEC 2013
- Country
- ECF United States
- ALEC United States
- Employees
- ECF N/A
- ALEC N/A
- Industry
- ECF Finance/Investors Services
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ECF Finance
- ALEC Health Care
- Exchange
- ECF Nasdaq
- ALEC Nasdaq
- Market Cap
- ECF 118.6M
- ALEC 101.1M
- IPO Year
- ECF N/A
- ALEC 2019
- Fundamental
- Price
- ECF $9.77
- ALEC $1.22
- Analyst Decision
- ECF
- ALEC Buy
- Analyst Count
- ECF 0
- ALEC 7
- Target Price
- ECF N/A
- ALEC $4.70
- AVG Volume (30 Days)
- ECF 57.7K
- ALEC 1.2M
- Earning Date
- ECF 01-01-0001
- ALEC 05-08-2025
- Dividend Yield
- ECF 6.42%
- ALEC N/A
- EPS Growth
- ECF N/A
- ALEC N/A
- EPS
- ECF 0.46
- ALEC N/A
- Revenue
- ECF N/A
- ALEC $88,339,000.00
- Revenue This Year
- ECF N/A
- ALEC N/A
- Revenue Next Year
- ECF N/A
- ALEC $392.45
- P/E Ratio
- ECF $17.61
- ALEC N/A
- Revenue Growth
- ECF N/A
- ALEC N/A
- 52 Week Low
- ECF $7.02
- ALEC $0.87
- 52 Week High
- ECF $8.91
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- ECF 70.94
- ALEC 54.59
- Support Level
- ECF $9.69
- ALEC $1.01
- Resistance Level
- ECF $9.34
- ALEC $1.26
- Average True Range (ATR)
- ECF 0.15
- ALEC 0.11
- MACD
- ECF 0.08
- ALEC 0.01
- Stochastic Oscillator
- ECF 91.01
- ALEC 67.30
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.